ALGS
Aligos Therapeutics
$5.03
−$0.14 (−2.71%)Oct 29, 2026
Key metrics
The numbers that frame ALGS today
- Market cap
- $62.82M
- Gross margin
- 100%
- EV / Sales
- 1.1
- ROIC
- -228.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.98
- 52wk High
- $13.69
Growth
Revenue and earnings trend for ALGS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ALGS
Is Aligos Therapeutics a good buy?
No. Aligos Therapeutics has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Aligos Therapeutics is selling at a very high price.
What is the market capitalization of ALGS?
Aligos Therapeutics's market capitalization is $62.82M.
What is the 52-week high for ALGS stock?
The 52-week high for Aligos Therapeutics is $13.69. The current close of $5.03 is 63.3% below that high.
What is the 52-week low for ALGS stock?
The 52-week low for Aligos Therapeutics is $3.98. The current close of $5.03 is 26.4% above that low.
Does ALGS stock pay dividends?
Aligos Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALGS?
Aligos Therapeutics's Debt / Equity ratio is 0.11.